CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-15 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −12,900 | 56,467 | ||
| 2021-06-08 | Paul Robert Chief Medical Officer | Option exercise | +7,292 | $8.16 | $60K | 281,011 |
| 2021-06-08 | Paul Robert Chief Medical Officer | Option exercise | +11,883 | $10.14 | $120K | 292,894 |
| 2021-06-08 | Paul Robert Chief Medical Officer | Sale | −16,175 | $19.00 | $307K | 276,719 |
| 2021-06-08 | Paul Robert Chief Medical Officer | Sale | −2,200 | $19.89 | $44K | 274,519 |
| 2021-06-08 | Paul Robert Chief Medical Officer | Sale | −800 | $20.83 | $17K | 273,719 |
| 2021-06-08 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −7,292 | 115,083 | ||
| 2021-06-08 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −11,883 | 42,284 | ||
| 2021-06-02 | Yu Calvin Vice President, Finance | Sale | −1,844 | $17.77 | $33K | 126,686 |
| 2021-05-21 | Paul Robert Chief Medical Officer | Option exercise | +14,191 | $8.16 | $116K | 287,910 |
| 2021-05-21 | Paul Robert Chief Medical Officer | Option exercise | +784 | $10.14 | $8K | 288,694 |
| 2021-05-21 | Paul Robert Chief Medical Officer | Sale | −14,975 | $18.14 | $272K | 273,719 |
| 2021-05-21 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −14,191 | 122,375 | ||
| 2021-05-21 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −784 | 54,167 | ||
| 2021-05-18 | Paul Robert Chief Medical Officer | Option exercise | +2,900 | $8.16 | $24K | 276,619 |
| 2021-05-18 | Paul Robert Chief Medical Officer | Option exercise | +1,300 | $10.14 | $13K | 277,919 |
| 2021-05-18 | Paul Robert Chief Medical Officer | Sale | −4,200 | $18.04 | $76K | 273,719 |
| 2021-05-18 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −2,900 | 136,566 | ||
| 2021-05-18 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −1,300 | 54,951 | ||
| 2021-05-07 | Yu Calvin Vice President, Finance | Grant or award | +16,000 | 126,686 |
Page 20 of 23 · 454 trades